Company / Gross Profit
Yubo International Biotech Ltd Gross Profit History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Gross Profit
$8.2K
FY2025
5-year range
$2.6K / $1.2M
FY2021-FY2025
Trend
+208.3%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Gross Profit changed +208% YoY in FY2025, a notable deviation from the 4-year average annual change of +177%.
Based on SEC 10-K filings.
$8,165 in FY2025 with a 5-year CAGR of -63.4%.
Declined from $419,185 to $8,165 over the past 2 years.
Gross Profit over time
Growth rates
- 3-Year CAGR
- -46.3%
- 5-Year CAGR
- -63.4%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of -63.4%, indicating a declining trend.
- In FY2025, gross profit increased 208.3% year-over-year.
- Peak gross profit was recorded in FY2020.
- Lowest gross profit in the period was in FY2024.
Company context
Key Data Points
- Altman Z-Score -14.17 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Gross ProfitValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $8.2K | +208.3% |
| FY2024 | $2.6K | -99.4% |
| FY2023 | $419.2K | +696.1% |
| FY2022 | $52.7K | -95.8% |
| FY2020 | $1.2M | - |
| FY2019 | - | - |
| FY2018 | - | - |
| FY2017 | - | - |
| FY2016 | - | - |
| FY2015 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 29, 2026